Vericel Corp. (VCEL)
40.50
+0.60
(+1.50%)
USD |
NASDAQ |
Sep 01, 10:01
Vericel Total Long Term Debt (Quarterly) : 80.41M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.41M |
| March 31, 2026 | 82.36M |
| December 31, 2025 | 84.30M |
| September 30, 2025 | 85.95M |
| June 30, 2025 | 87.78M |
| March 31, 2025 | 89.77M |
| December 31, 2024 | 90.58M |
| September 30, 2024 | 91.59M |
| June 30, 2024 | 90.00M |
| March 31, 2024 | 86.30M |
| December 31, 2023 | 81.96M |
| September 30, 2023 | 77.80M |
| June 30, 2023 | 76.19M |
| March 31, 2023 | 42.38M |
| December 31, 2022 | 43.31M |
| September 30, 2022 | 43.22M |
| June 30, 2022 | 45.03M |
| March 31, 2022 | 46.11M |
| December 31, 2021 | 47.23M |
| September 30, 2021 | 48.58M |
| June 30, 2021 | 47.03M |
| March 31, 2021 | 48.07M |
| December 31, 2020 | 48.91M |
| September 30, 2020 | 21.60M |
| June 30, 2020 | 21.02M |
| Date | Value |
|---|---|
| March 31, 2020 | 21.73M |
| December 31, 2019 | 22.39M |
| September 30, 2019 | 25.46M |
| June 30, 2019 | 24.78M |
| March 31, 2019 | 0.166M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 17.28M |
| June 30, 2018 | 17.26M |
| March 31, 2018 | 17.25M |
| December 31, 2017 | 17.24M |
| September 30, 2017 | 9.957M |
| June 30, 2017 | 10.16M |
| March 31, 2017 | 3.099M |
| December 31, 2016 | 10.13M |
| September 30, 2016 | 0.042M |
| June 30, 2016 | 0.052M |
| March 31, 2016 | 0.062M |
| December 31, 2015 | 0.071M |
| September 30, 2015 | 0.081M |
| June 30, 2015 | 0.091M |
| March 31, 2015 | 0.10M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.153M |
| June 30, 2014 | 2.50M |
| March 31, 2014 | 0.002M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| AbbVie, Inc. | 70.82B |
| ADMA Biologics, Inc. | 202.66M |
| Kyntra Bio, Inc. | 0.00 |
| Conexeu Sciences, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 59.55M |